Status:
COMPLETED
Cognitive Function in Multiple Sclerosis
Lead Sponsor:
Inonu University
Conditions:
Multiple Sclerosis
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
The aim of the study is to investigate the relationship between cognitive function, functional capacity, cognitive reserve and reaction time in patients with multiple sclerosis.
Detailed Description
Cognitive impairment in patients with MS is a common problem that significantly affects quality of life. It shows an association between functional capacity and physical fitness levels and cognition i...
Eligibility Criteria
Inclusion
- Relapsing-remitting MS diagnosis
- Expanded Disability Status Scale score \<5.5
- Being able to use a smart phone
- No relapse during the last 30 days
- Being between the ages of 18-65
- Mini-Mental State Examination score\>24
Exclusion
- Severe Visual Impairment
- Severe Psychiatric Disorder,
- Severe Arthritis in Knee or Hip,
- Pregnancy and other neurological or vestibular disorders that may prevent the patient from completing the functional examination
Key Trial Info
Start Date :
November 15 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 15 2022
Estimated Enrollment :
76 Patients enrolled
Trial Details
Trial ID
NCT06084182
Start Date
November 15 2021
End Date
November 15 2022
Last Update
October 16 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Inonu University
Malatya, Turkey (Türkiye)